ADVERTISEMENT
Infographic
The Efficacy and Safety of an Oral Phosphodiesterase 4B (PDE4B) Inhibitor, BI 1015550, in Patients With Idiopathic Pulmonary Fibrosis (IPF): A Phase 2 Clinical Trial
Reviewed by Elizabeth Volkmann, MD, MS
Reviewed by Elizabeth Volkmann, MD, MS
07/24/2024
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 21
Issue 2
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter